Therefore, the aim of the study was to analyse the concentration of soluble tumour necrosis factor ligand inducing apoptosis (sTRAIL) and its osteoeprotegerine receptor (OPG) in the serum of women with serous or mucinous ovarian cancer, taking into account the histological differentiation of the cancer. Here, TNFRSF11B is linked to mucinous ovarian cancer.